These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6143633)

  • 21. Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation.
    Ochs HR; Greenblatt DJ; Knüchel M
    Br J Clin Pharmacol; 1983 Dec; 16(6):743-6. PubMed ID: 6140941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetics of brotizolam and triazolam in healthy subjects.
    Jochemsen R; Wesselman JG; van Boxtel CJ; Hermans J; Breimer DD
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):291S-297S. PubMed ID: 6140948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Lab Clin Med; 1983 Jun; 101(6):873-80. PubMed ID: 6133901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of alprazolam on digoxin kinetics and creatinine clearance.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B
    Clin Pharmacol Ther; 1985 Nov; 38(5):595-8. PubMed ID: 2865030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population study of triazolam pharmacokinetics.
    Friedman H; Greenblatt DJ; Burstein ES; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1986 Dec; 22(6):639-42. PubMed ID: 3567010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-alpha] [1,4] benzodiazepine, triazolam, a new central depressant. I. Absorption, distribution and excretion in rats, dogs and monkeys.
    Kitagawa H; Esumi Y; Kurosawa S; Sekine S; Yokoshima T
    Xenobiotica; 1979 Jul; 9(7):415-28. PubMed ID: 40350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of influence of cigarette smoking on triazolam pharmacokinetics.
    Ochs HR; Greenblatt DJ; Burstein ES
    Br J Clin Pharmacol; 1987 Jun; 23(6):759-63. PubMed ID: 3606935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration.
    Smith RB; Kroboth PD; Phillips JP
    J Clin Pharmacol; 1986 Feb; 26(2):120-4. PubMed ID: 3950055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
    Greenblatt DJ; Wright CE
    Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of subject age and gender on the pharmacokinetics of oral triazolam and temazepam.
    Smith RB; Divoll M; Gillespie WR; Greenblatt DJ
    J Clin Psychopharmacol; 1983 Jun; 3(3):172-6. PubMed ID: 6135721
    [No Abstract]   [Full Text] [Related]  

  • 31. Alprazolam pharmacokinetics in alcoholic liver disease.
    Juhl RP; Van Thiel DH; Dittert LW; Smith RB
    J Clin Pharmacol; 1984; 24(2-3):113-9. PubMed ID: 6143766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam.
    Yuan R; Flockhart DA; Balian JD
    J Clin Pharmacol; 1999 Nov; 39(11):1109-25. PubMed ID: 10579141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys.
    Gomez TH; Roache JD; Meisch RA
    Psychopharmacology (Berl); 2002 Apr; 161(1):86-94. PubMed ID: 11967635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Benzodiazepines: significance of kinetics for therapy].
    Ochs HR
    Klin Wochenschr; 1983 Mar; 61(5):213-24. PubMed ID: 6405081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triazolam and ethanol interaction: kinetic and dynamic consequences.
    Dorian P; Sellers EM; Kaplan HL; Hamilton C; Greenblatt DJ; Abernethy D
    Clin Pharmacol Ther; 1985 May; 37(5):558-62. PubMed ID: 2859136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the anxiolytic and amnesic effects of three benzodiazepines, diazepam, alprazolam and triazolam, by conflict and non-matching to sample tests in mice.
    Kuribara H; Asahi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Feb; 17(1):1-6. PubMed ID: 9134532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity effects on nitrazepam disposition.
    Abernethy DR; Greenblatt DJ; Locniskar A; Ochs HR; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1986 Nov; 22(5):551-7. PubMed ID: 3790401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics.
    Kroboth PD; Smith RB; Silver MR; Rault R; Sorkin MI; Puschett JB; Juhl RP
    Br J Clin Pharmacol; 1985 Jun; 19(6):839-42. PubMed ID: 2862896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged accumulation of diazepam in obesity.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Clin Pharmacol; 1983; 23(8-9):369-76. PubMed ID: 6415130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced bioavailability of triazolam following sublingual versus oral administration.
    Scavone JM; Greenblatt DJ; Friedman H; Shader RI
    J Clin Pharmacol; 1986 Mar; 26(3):208-10. PubMed ID: 3958225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.